SEC Form D · filed December 30, 2016
Strongbridge Biopharma plc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (26)
Garheng H. Kong · Trevose, PADirectorStephen B. Long · Trevose, PAExecRichard H. Kollender · Trevose, PADirectorMatthew Pauls · Trevose, PAExec · DirectorRobert B. Lutz · Trevose, PAExecHilde H. Steineger · Trevose, PADirectorMarten H. Steen · Trevose, PADirectorJohn H. Johnson · Trevose, PADirectorA. B. Davis · Trevose, PAExecRobbie Vann-Adibe · San Francisco, CADirectorSteven E. Hubbard · McMinnville, TNExecDermot Butler · Dublin 2, IrelandDirectorDavid Chancogne · San Francisco, CADirectorJeffrey W. Sherman · Trevose, PADirectorFredric B. Cohen · Trevose, PAExecSmith Donn · Grand Rapids, MIExec · DirectorJohn Skelly · Dublin 2, IrelandDirectorAlan Tooker · Dublin 2, IrelandExec · DirectorMarie-Caroline Stievenart · Dublin 2, IrelandExec · DirectorRoss H. Martinson · New York, NYDirectorJohn H. Watts · New York, NYDirectorTorrance Robinson · New York, NYDirectorJohn Aiello · New York, NYExec · DirectorJeffrey W. Sherman · Trevose, PADirectorA. B. Davis · East Norriton, PAExecFredric B. Cohen · Trevose, PAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗